Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)

Market Cap	26.42B +18.4%
Revenue (ttm)	2.31B +14.2%
Net Income	468.50M +24.2%
EPS	0.79 +24.1%
Shares Out	587.30M
PE Ratio	56.73
Forward PE	47.83
Dividend	0.52 (1.15%)
Ex-Dividend Date	Jun 22, 2026

Volume	291,670
Open	44.97
Previous Close	44.99
Day's Range	44.40 - 45.12
52-Week Range	32.16 - 45.25
Beta	0.90
Analysts	Buy
Price Target	45.13 (+0.07%)
Est. Earnings	Nov 24, 2026

About NZE:FPH

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 7,434
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: FPH

Financial Performance

In fiscal year 2026, NZE:FPH's revenue was 2.31 billion, an increase of 14.22% compared to the previous year's 2.02 billion. Earnings were 468.50 million, an increase of 24.20%.

Analyst Summary

According to 12 analysts, the average rating for FPH stock is "Buy." The 12-month stock price target is $45.13, which is an increase of 0.07% from the latest price.

Price Target

$45.13

(0.07% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 24, 2026

Data Sources Report a data error